We are live on ! Find out more
SIC

SJS Investment Consulting Portfolio holdings

AUM $919M
1-Year Est. Return 23.4%
This Fund
S&P 500
This Quarter Est. Return
+6.26%
1 Year Est. Return
+23.4%
3 Year Est. Return
+63.82%
5 Year Est. Return
10 Year Est. Return
AUM
$398M
AUM Growth
+$31.5M
Cap. Flow
+$9.86M
Cap. Flow %
2.48%
Top 10 Hldgs %
83.55%
Holding
1,636
New
57
Increased
580
Reduced
641
Closed
44

Sector Composition

Rank Sector Weight
1 Consumer Staples 6.44%
2 Technology 4.73%
3 Healthcare 3.23%
4 Consumer Discretionary 2%
5 Financials 1.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UCTT
1501
Ultra Clean Holdings
UCTT
$3.82B
$116 ﹤0.01%
3
-2
-40% -$64
AMPH icon
1502
Amphastar Pharmaceuticals
AMPH
$871M
$115 ﹤0.01%
2
+1
+100% +$44
SRPT icon
1503
Sarepta Therapeutics
SRPT
$1.76B
$115 ﹤0.01%
+1
New +$129
PTVE
1504
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$114 ﹤0.01%
15
+12
+400% +$92
LRN icon
1505
Stride
LRN
$3.39B
$112 ﹤0.01%
3
AJRD
1506
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$110 ﹤0.01%
2
NFE icon
1507
New Fortress Energy
NFE
$97.4M
$108 ﹤0.01%
+4
New +$116
RVMD icon
1508
Revolution Medicines
RVMD
$44.2B
$107 ﹤0.01%
4
+2
+100% +$49
XPRO icon
1509
Expro Ltd
XPRO
$1.95B
$107 ﹤0.01%
+6
New +$108
AD
1510
Array Digital Infrastructure
AD
$3.04B
$106 ﹤0.01%
6
-3
-33% -$53
PLTK icon
1511
Playtika
PLTK
$1.07B
$105 ﹤0.01%
9
+5
+125% +$54
TGLS icon
1512
Tecnoglass Holdings Inc.
TGLS
$1.88B
$104 ﹤0.01%
+2
New +$89
HAYW icon
1513
Hayward Holdings
HAYW
$3.3B
$103 ﹤0.01%
+8
New +$92
BCRX icon
1514
BioCryst Pharmaceuticals
BCRX
$2.46B
$99 ﹤0.01%
14
SCPL
1515
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
$99 ﹤0.01%
5
+1
+25% +$18
CYTK icon
1516
Cytokinetics
CYTK
$10.4B
$98 ﹤0.01%
3
NBTB icon
1517
NBT Bancorp
NBTB
$2.73B
$96 ﹤0.01%
3
FSLY icon
1518
Fastly Inc
FSLY
$4.36B
$95 ﹤0.01%
+6
New +$92
MMI icon
1519
Marcus & Millichap
MMI
$1.15B
$95 ﹤0.01%
3
+2
+200% +$62
ASTH icon
1520
Astrana Health
ASTH
$1.86B
$95 ﹤0.01%
3
OLPX
1521
DELISTED
Olaplex Holdings
OLPX
$93 ﹤0.01%
25
BANF icon
1522
BancFirst
BANF
$3.79B
$92 ﹤0.01%
1
-5
-83% -$421
ALGM icon
1523
Allegro MicroSystems
ALGM
$7.97B
$91 ﹤0.01%
+2
New +$81
MODV
1524
DELISTED
ModivCare
MODV
$91 ﹤0.01%
2
+1
+100% +$59
IAS
1525
DELISTED
Integral Ad Science
IAS
$90 ﹤0.01%
+5
New +$84

Similar funds

SJS Investment Consulting's Q2 2023 Portfolio in Review

As of Q2 2023, SJS Investment Consulting held 1,636 positions worth $398M, up 8.6% from $367M the previous quarter. Its ten largest holdings account for 84% of the portfolio.

SJS Investment Consulting's Q2 2023 filing shows 57 new, 580 increased, 641 reduced and 44 closed positions. Its largest new stake was Stantec: 1,253 shares worth $81.7K. The largest sale was Vanguard Ultra-Short Bond ETF, an estimated $856K.

By sector, the portfolio is most concentrated in Consumer Staples at 6.4% of assets, down from 6.8% a quarter earlier, followed by Technology and Healthcare.

  • SJS Investment Consulting's largest Q2 2023 buy was Stantec: 1,253 shares worth $81.7K.
  • SJS Investment Consulting added most to Dimensional US Core Equity 2 ETF in Q2 2023, an estimated $5.23M increase.
  • SJS Investment Consulting's biggest Q2 2023 reduction was Vanguard Ultra-Short Bond ETF, cutting an estimated $856K.
  • SJS Investment Consulting fully exited W.P. Carey in Q2 2023, selling an estimated $36.4K.
  • SJS Investment Consulting's ten largest holdings make up 84% of its $398M portfolio in Q2 2023.
  • SJS Investment Consulting opened 57 new positions and closed 44 in Q2 2023.
  • SJS Investment Consulting's portfolio value rose 8.6% quarter-over-quarter to $398M.

Based on SJS Investment Consulting's 13F filing for Q2 2023, filed 13 Jul 2023.